2020
P13 Major depressive disorder in patients with wilson’s disease: relationship with liver disease, neurological disease and quality of life
Camarata M, Ala A, Maciejewski K, To U, Zimbrean P, Rubman S, Patel A, Wadhwa A, Coskun A, Apdik T, Tomlin R, Deng Y, Schilsky M. P13 Major depressive disorder in patients with wilson’s disease: relationship with liver disease, neurological disease and quality of life. Gut 2020, 69: a13-a13. DOI: 10.1136/gutjnl-2020-basl.24.Peer-Reviewed Original ResearchMajor depressive disorderQuality of lifeMental health QOLWilson's diseaseNeurological diseasesLiver diseaseDepressive disorderFirst presentationExact testDepression symptomologySeverity of liverLifetime major depressive disorderLiver disease severityFisher's exact testPhysical health QOLSignificant differencesWilcoxon rank sum testMental health problemsRank sum testFIB4 scoreClinical featuresNeurological assessmentPHQ-9PatientsCurrent depression
2013
730
McGinniss J, Marshall P, Schilsky M, Honiden S. 730. Critical Care Medicine 2013, 41: a180-a181. DOI: 10.1097/01.ccm.0000439968.28678.d4.Peer-Reviewed Original ResearchCerebral edemaInvasive ICP monitorTH groupICP monitorALF patientsIntracranial pressureExact testMolecular adsorbent recirculating system dialysisRed blood cell transfusion requirementsYale-New Haven HospitalHepatic synthetic functionNon-TH groupMcg/dlChronic liver diseaseSimilar demographic dataFresh frozen plasmaUncontrolled intracranial pressureFeasible therapeutic modalityFisher's exact testNew Haven HospitalAdvanced hepatic encephalopathyT-testStudent's t-testTH initiationTransfusion requirements